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ABSTRACT

The Impact and Efficacy of Diabetes Education Programs among Adults
by
Mireille Hamdan

The purpose of this study was to measure the impact of diabetes education classes in increasing
knowledge and promoting healthy lifestyle behaviors. Thirty-three subjects participated in the
classes between October 2004 and October 2005. Only six subjects agreed to participate in this
study. Changes in knowledge after the classes were measured by a survey test one year following
the completion of classes. Survey responses were analyzed using percentages. Subject’s Hgb
A1C and weights were also collected to measure the direct impact of education on participants’
blood glucose management. Overall, participants were very knowledgeable of diabetes
symptoms, complications, carbohydrate counting, and serving sizes after the nutrition
intervention.
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CHAPTER 1
INTRODUCTION

Diabetes is a metabolic disorder in which there is little or no control of blood sugar
through inadequate insulin production (Type 1 or insulin dependent diabetes) or decreased
cellular sensitivity to insulin (Type 2 or non-insulin dependent diabetes). Insulin is needed
to convert sugar into energy for daily life. Both genetics and environmental factors, such
as obesity and lack of exercise, play important roles in the occurrence of this metabolic
disorder (1).
Diabetes has become increasingly common in the United States. In 2002, the number
of Americans with diabetes was estimated of 18.2 million, yet only 13 million people were
diagnosed (2). Approximately 8.7 % of people 20 years or older have diabetes, and the
percentage rises to 18.3 % for people 60 years or older (3). In 2002, the cost of diabetes
care in the United States was estimated at $132 billion (4). Direct medical expenditures
related to diabetes in 2002 was estimated at $91.8 billion which was divided into $23.2
billion for diabetes care, $24.6 billion for chronic complications accompanied with
diabetes, and $44.1 billion for general medical conditions. Indirect costs, totaling $40.8
billion, were associated with lost productivity including premature death and disability.
Statistics also indicated that 51.8% of direct medical expenditures were incurred by people
65 years and older (4).
The risk of death is higher among people having diabetes due to the complications
associated with the disease. Diabetes increases the risk of kidney disease, blindness
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(retinopathy), heart disease, stroke, high blood pressure, and nervous system disease
(neuropathy) (2). Studies indicate that diabetes prevention or delay is possible by
consuming healthier diets and getting physical activity (5).

Statement of the Problem
The purpose of this study was to measure the impact of diabetes education classes in
increasing knowledge and promoting healthy lifestyle behaviors. Diabetes afflicts more
than 18 million people in the United States. It is a main cause of kidney failure and
blindness and is implicated as a major cause of heart disease and stroke (6). Subjects with
Type 2 diabetes (non insulin-dependent diabetes mellitus), or adult onset diabetes,
represent up to 90 % of all diabetes cases. It is most common in adults over age 40, and it
is strongly associated with obesity, inactivity, and a family history of diabetes; 90% of
Type 2 diabetics are obese. The increasing incidence of Type 2 diabetes demands effective
out-patient programs for people with diabetes in order to improve their quality of life (6).

Significance of the Problem
Diabetes mellitus contributes to a considerable increase in morbidity and mortality rates
every year. The risk for death among people with diabetes is about two times that of
people without diabetes (2). The cost of treating diabetes and its complications or
compensating for disability resulting from diabetes is high; $132 billion was spent in the
year 2002. The direct cost of medical care is $13,243 / person /year with diabetes
compared with $2560 per person without diabetes (4). The problem is significant, but
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many solutions are available beginning with dietary intervention and increasing the level of
physical activity (5).
Hypothesis
Participation in a diabetes education program will result in significantly better glycemic
and weight control for participants in a diabetes education program.

Null-hypothesis
There will be no significant difference in weight and glycemic control after
participating in a diabetes education program.

Limitations
Limitations of this study include:
1. Lack of consistency due to the nutrition programs being presented by two different
instructors, unexpected absence of the participants in classes, and participants dropping
out of the program for a variety of reasons.
2. Subjects could improve glycemic control independently of weight loss.
3. There was no control of motivational state of the participants.
4. The effect of medications or insulin was not taken into consideration among
participants. Some subjects could be taking both insulin and oral medications; others
will be taking either one of them.
5. Small group sample size.
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Assumptions
Assumptions of this study include:
1. Patients will provide honest answers to the survey questions.
2. The researcher assumed that the changes in Hemoglobin A1C test and in the body
weight were only due to the quality of the diet and not affected by any other
physiological changes.

Definition of Terms
Metabolic Syndrome- defined as abdominal obesity and insulin resistance accompanied
with an increased risk for cardiovascular disease and Type 2 diabetes. The risk factors
include elevated low-density lipoprotein, decreased high-density lipoprotein, elevated
triglyceride, hypertension, and impaired glucose tolerance (7).
Obesity- is an increase in fat cells proportion in the viscera and subcutaneous tissues of
the body resulting in a body mass index (BMI) greater than 30. (7).
Keto-acidosis- incomplete oxidation of fat in the body in which ketone bodies build up
in the blood, resulting from an insufficient availability of insulin to allow proper action of
glucose for energy (7).
Type 1 diabetes- known as insulin dependent diabetes mellitus, results from absolute
insulin deficiency secondary to β-cell destruction and leading to hyperglycemia. Persons
with Type 1 diabetes are dependent on exogenous insulin (7).
Type 2 diabetes- known as non-insulin dependent diabetes mellitus, results from a
combination of cellular insulin resistance and insulin deficiency. The endogenous insulin
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level may be normal or elevated but inadequate to overcome the decreased tissue sensitivity
to insulin (7).
Gestational diabetes - any degree of glucose intolerance recognized during second and
third trimester of pregnancy (7).
Hypoglycemia- defined as low blood glucose level < 70mg/dl which can be a result of
low food intake or an excessive insulin administration (7).
Hyperglycemia- defined as high blood glucose levels (7).
Hemoglobin A1C- HgbA1C reflects blood glucose levels over the past 120 days (7).
Lipolysis- the breakdown of fat stored in fat cells. During this process free fatty acids
are released and ketones are produced (7).
Insulin resistance- tissue sensitivity to endogenous and exogenous insulin is decreased
due to an impaired biologic response (7).
Macrovascular diseases- diseases related to large blood vessels, includes peripheral
vascular disease, cardiovascular disease, and coronary artery disease (7).
Microvascular disease- disease related to the small blood vessels like retinopathy and
nephropathy (7).
Postprandial blood glucose- blood glucose level after eating (7)
Fasting blood glucose- defined as the level of blood glucose in the morning before
eating (7).
Impaired Glucose tolerance (IGT) - called pre-diabetes, defined as an elevated blood
glucose level, two hours after a meal, greater than or equal to 140 and less than 200mg/dl
(7).
Hypertension- is an elevated blood pressure level exceeding 140/90 mmHg (7).
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Hyperglycemic Hyperosmolar State (HHS) - is characterized by high blood glucose
levels with absence of ketosis and dehydration (7).
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CHAPTER 2
REVIEW OF LITERATURE

Diabetes is one of the most important clinical and public health problems facing the
world today (8, 9). Diabetes is a group of metabolic diseases characterized by
hyperglycemia resulting from defects in insulin secretion, insulin action, or both (10). The
development of diabetes may be due to pathogenic processes, ranging from the
autoimmune destruction of the beta-cells of the pancreas causing insulin deficiency to
cellular disturbances resulting in insulin resistance (10, 11). Insulin deficiency may be due
to inadequate secretion or diminished tissue response to insulin in the complex pathway of
hormone action; these result in disturbances in carbohydrate, fat, and protein metabolism
(11, 12).

Classification of Diabetes
The majority of diabetes cases fall into one of four categories: Type 1, Type 2,
gestational diabetes, or pre-diabetes (10).

Type 1 Diabetes
This type was known previously as insulin-dependent diabetes, or juvenile-onset
diabetes. The primary cause of Type 1 diabetes is pancreatic beta-cell destruction leading
to absolute deficiency of insulin secretion (13, 14) and resulting in hyperglycemia.
Symptoms of hyperglycemia include excessive urination, excessive thirst, dehydration,
electrolyte disturbance, and keto-acidosis. Type 1 diabetes may be caused by an
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autoimmune pathologic process occurring in the pancreatic islets or by genetic markers.
These markers could be islet cell auto-antibodies (ICAs), auto-antibodies to insulin (IAAs),
or auto-antibodies to glutamic acid decarboxylase which is a protein on the surface of betacells (8, 14). People with Type 1 diabetes require exogenous sources of insulin to control
their blood sugar levels. It develops most often in children and young adults and accounts
for about 5% to 10% of diagnosed diabetes in the United States. Patients are rarely obese
when they present with this type of diabetes, and they are typically at high risk for ketoacidosis due to poor glycemic control (13, 14).

Type 2 Diabetes
This type is known as non-insulin-dependent diabetes, Type 2 diabetes, or adult-onset
diabetes. The cause is a combination of insulin resistance and inadequate compensatory
insulin secretion response resulting in hyperglycemia (14, 15). This form of diabetes is
frequently undiagnosed in the early stages. Insulin resistance is first demonstrated in target
tissues, mainly muscle tissues and the liver. Initially there is a compensatory increase in
insulin secretion. This process will maintain normal glucose concentrations, but as the
disease progresses, insulin production gradually decreases. Hyperglycemia begins with an
elevation of the postprandial blood glucose due to insulin resistance at the cellular level,
and it is followed by an elevation in fasting glucose concentrations (14, 16, 17). As insulin
secretion decreases; hepatic glucose production and pre-prandial blood glucose increase
(7, 14). The risk of developing Type 2 diabetes increases with age, obesity, and lack of
physical activity. The obesity is not only measured by the traditional weight criteria, but it
is also associated with an increased percentage of body fat distributed predominantly in the
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abdominal region (14, 17). In addition, Type 2 diabetes is associated with a strong genetic
predisposition (7, 18).

Gestational Diabetes
This type is discovered during pregnancy and usually disappears when the pregnancy
is over. Women who have had gestational diabetes have a grater risk of developing Type 2
diabetes later in their lives (7, 15, 19).

Pre-Diabetes
A pre-diabetes stage includes the impaired fasting glucose (IFG) and impaired glucose
tolerance (IGT). Impaired fasting glucose represents a metabolic stage of impaired glucose
homeostasis intermediate between normal and diabetes. Impaired glucose tolerance is
associated with increased macro-vascular disease. This stage of impaired glucose
homeostasis or pre-diabetes is not a category of diabetes mellitus but it indicates a high risk
for future diabetes (7, 10, 14).

Diagnostic Criteria for Diabetes Mellitus and Pre-Diabetes
Diabetes mellitus is diagnosed using one of three methods and must be confirmed
on a subsequent day (7, 20).
- Random plasma glucose is greater than or equal to 200 mg/dl.
- Fasting plasma glucose is greater than or equal to 126 mg/dl.
- Two-hour postprandial plasma glucose is greater than or equal to 200 mg/dl
during a 75 g oral glucose tolerance test (OGTT).
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Impaired fasting glucose (IFG) is diagnosed when fasting glucose levels are greater
than or equal to 100 mg/dl but less than 126 mg/dl (14, 20). Impaired glucose tolerance is
diagnosed when two-hour oral glucose tolerance test (OGTT) values are greater than or
equal to 140mg/dl but less than 200 mg/dl. So, the normal fasting glucose is less than
100mg/dl and normal OGTT is less than 140 mg/dl (14, 20).

Hemoglobin A1C
Hemoglobin A1C test (HgbA1C test) is also called the diabetic control index and
glycosylated or glycated hemoglobin. It is a test that indicates the quantity of glucose in
the blood during the preceding period of two to four months. A routine blood sugar test
reveals how close to normal the glucose level is at the time of the test (21, 22).
The hemoglobin A1C test measures the percentage of hemoglobin bound to glucose.
Hemoglobin is a protein found in the blood cells. Hemoglobin and glucose, found in red
blood cells (RBC), bind to the A1C form of hemoglobin in a process called glycosylation.
The amount bound reflects how much glucose has been in the blood during the past
average 120 day lifespan of RBC. This can be measured by several methods such as
electrophoresis, chromatography, and immunoassay which are all based on the separation
of hemoglobin bound to glucose from that without glucose (22). The American Diabetes
Association recommends that this test should be done during the first diagnosis of diabetes,
again after the beginning of the treatment, and than repeated every six months; if the person
does not meet the treatment goals, it should be repeated every three months (21, 22).
According to Edelman et al. and Peters et al. the following categories were defined based
on HgbA1C results for persons without prior diagnosis of diabetes: normal- HgbA1C <6%;
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high risk for diabetes- HgbA1C 6%-6.99%; new diabetes- HgbA1C 7% (23, 24).
Hemoglobin A1C is a better screening test for diabetes than random glucose. The mean
serum glucose was 100mg/dl  22 mg/dl for persons without prior diagnosed diabetes and
with a HgbA1C between 6% and 7%. For those with HgbA1C test of 7 % the mean
random glucose was 153mg/dl 62mg/dl (24). So, the measurement of HgbA1C is
essential for early diagnosis and long-term monitoring of blood glucose in patients with
diabetes (24).

Complications and Risk Factors of Diabetes
Obesity is one of the greatest risk factors for Type 2 diabetes. Particularly, abdominal
obesity is one of the factors leading to plurimetabolic abnormalities known as insulin
resistance syndrome (25, 26). Insulin resistance at the adipocyte level leads to lipolysis and
an elevation in the circulating free fatty acids. An increase in free fatty acids will cause a
further decrease in insulin sensitivity at the cellular level that will impair pancreatic insulin
secretion and at the same time increase hepatic glucose production (14, 16). In addition an
increase in free fatty acids in the blood will increase the blood pressure and triglycerides
which are two other risk factors for insulin resistance syndrome and lead to cardiovascular
disease (26, 27).
Two different categories of diabetes complications are defined: acute complications and
long-term complications (10).
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Acute Complication
The acute complications related to diabetes are hypoglycemia, diabetic keto-acidosis,
and hyperglycemia. With insulin therapy it is extremely difficult to have good glycemic
control. Sometimes blood glucose will drop suddenly to a level lower than or equal to 70
mg/dl causing hypoglycemia that must be treated immediately. Symptoms of
hypoglycemia include sweating, trembling, difficulty concentrating, and lightheadedness.
With progression to severe hypoglycemia the diabetic will be not able to self-treat due to
mental confusion, and sometimes if left untreated this may result in a loss of consciousness
(14, 28).
Prolonged hyperglycemia can lead to two types of acute metabolic complications:
diabetic keto-acidosis (DKA) and hyperosmolar hyperglycemic state (HHS). Keto-acidosis
is caused by inadequate insulin to use glucose for energy. It is a life-threatening
complication, but reversible; it is characterized by severe disturbances in carbohydrate,
protein, and fat metabolism (7, 15). In contrast, hyperosmolar hyperglycemic state is
caused by an excessive amount of blood glucose, with an absence of ketosis and profound
dehydration (7, 28).

Long-Term Complications
The most significant diabetes issues are the irreversible long-term complications. These
include macrovascular diseases or diseases of large blood vessels and microvascular
diseases that involve the small blood vessels (16).
Macrovascular disease includes coronary heart disease, peripheral vascular disease, and
cerebrovascular disease. Adults with diabetes have rates of heart disease and stroke two to
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four times higher than those without diabetes (29, 30). In fact, the development of
metabolic syndrome or insulin resistance syndrome will cause Type 2 diabetes and
subsequent macrovascular diseases. This metabolic syndrome is characterized by
abdominal obesity (waist circumference in men > 102 cm and in women >88 cm), and
associated with dyslipidemia where serum triglycerides are at least 150 mg/dl and high
density lipoprotein (HDL) cholesterol is <40mg/dl, hypertension (blood pressure > 130/ 80
mm Hg) and glucose intolerance (7, 20).
Microvascular diseases include retinopathy (eye disease), nephropathy (kidney
disease), and neuropathy or nerve damage due to chronic high blood glucose. Diabetic
retinopathy is the leading cause of blindness especially in adults after the age of 20 years.
After a long period of having diabetes, all people with Type 1 diabetes and 60% of Type 2
diabetics have some degree of retinopathy caused by this disease (14, 31). Diabetes is also
a common cause of end-stage renal disease in which 43 % of the cases require dialysis or
kidney transplantation (14, 32). In people with diabetes nerve damage occurs over time
and may lead to numbness, pain, and weakness in the hands, arms, feet, legs, digestive
tract, heart, and sex organs (14, 32).

Self-Management Education Program
The treatment of diabetes mellitus requires counseling on lifestyle modifications and
nutritional management (33). The increased marketing and availability of food has
contributed to the U.S. obesity epidemic and thus a higher occurrence of Type 2 diabetes
(34, 35). Consumers have been confused concerning correct portion sizes (34), and diet
therapy is very important to reduce risk factors such as overweight. Diabetes education
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should be an integral part of treatment of diabetes mellitus. The desired outcome of the
diabetes education is self-care knowledge and the empowerment of the patient in making
therapeutic decisions. Self-management programs have been widely reported to help the
people managing symptoms of diabetes. Such programs are separated from the clinical
patient care but work in collaboration with health care professionals (36). In other words,
diabetes self-management is training individuals to manage their diabetes, help optimize
metabolic control, prevent acute and chronic complications, and improve quality of life
while keeping costs at acceptable levels (37). In these programs specialists like registered
dietitians and nurses teach, counsel, make dietary recommendations, and suggest strategies
for self-management for the people with diabetes. Successful diabetes care programs are
patient centered and establish guidelines and specific responsibilities for each member of
the team. The focus, at the same time, is on specific outcomes and the way to achieve these
outcomes (9). Medical treatment of diabetes is used to lower blood glucose to normal
levels and hemoglobin A1C level to less than 7% (29, 38). The education program should
focus on the importance of constant monitoring, regular glucose testing and quarterly
review of Hemoglobin A1C. In order to achieve these goals the educational program
should focus on the importance of weight loss, reducing the risk of dyslipidemia, and
controlling carbohydrate intake (33). Basically the weight loss begins by reducing the total
energy and reducing the fat intake to less than 30% of energy intake. The reduction of
saturated fat intake (<10% of energy intake), cholesterol intake (< 300mg/day), and transunsaturated fatty acid are also recommended to reduce the risk of dyslipidemia. A high
fiber diet with a daily intake of 3g of soluble fiber can decrease the total cholesterol by
about 5mg/dl or 2% reduction (7, 33, and 39). The nutrition counseling includes the total
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amount of carbohydrate intake and the type of sugar intake (glucose, fructose, sucrose,
lactose) that will affect the weight loss and the level of glucose in the blood (9). Portioning
skills are also taught to emphasize the importance of weight loss (34).
Success of the self-management program can be attributed to helping patients set
reasonable goals and empowering them with the appropriate knowledge and skills to
achieve their goals (21). The long-term outcome of the program depends on increasing the
frequency of testing hemoglobin A1C, decreasing anthropometric measures, and increasing
knowledge (21).
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CHAPTER 3
DESIGN AND METHODOLOGY

Participants
Participants who attended education classes for diabetes between October 2004 and
October 2005 included 33 subjects having diabetes with an age range from 19 to 60 years.
These participants were enrolled in the “Caring For Your Diabetes” program sponsored by
Mountain States Health Alliance (MSHA). The subjects were employees of the MSHA
hospital system or their dependents. The education classes were offered free of charge to all
employees and dependents with diabetes and were held at the Health Resource Center in
the Johnson City Mall. Participants volunteered to be a part of the education program, and
as a result of participation they received free medications and supplies for the treatment of
their diabetes. All subjects agreed to participate in the study by signing a release form for
the Health Resource Center (HRC).

Instrumentation
The only instrument used in this research was a survey developed by the principal
investigator, reviewed by the research committee, and validated by seven MSHA
employees with different levels of education. The survey questions were developed and
based upon the education materials given in classes. All the questions were intended to
measure the degree of understanding of the participants in managing their diabetes
(Appendix A).
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Data Collection Procedure
Permission to conduct this study was received from The Research Board of MSHA and
the East Tennessee State University Institutional Review Board. The participants were
employees or dependents of employees in the hospital system of Mountain State Health
Alliance (MSHA) who had completed a series of three educational classes. They were
trained to manage their diabetes by decreasing their body weight and changing the type of
food they consumed. An informed consent, a HIPPA authorization, the survey and two
self-addressed stamped envelopes were mailed to the participants. After three weeks, a
follow up survey was mailed to those who had not previously responded. After receiving
completed surveys, HIPPA authorizations and the informed consents, all the data were
collected and analyzed. The collected data from the participants’ records at the HRC
included the results of the Hemoglobin A1C tests and the changes of the body weight.

Data Analysis
All the survey results, the hemoglobin A1C tests, and body weight changes were
gathered. Survey answer percentages and weight changes percentages were calculated and
can be found in the tables in Chapter 4. Hgb A1C and weight changes of each subject were
recorded, analyzed, and graphed.
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CHAPTER 4
RESULTS

The Sample
Participants in this study attended education classes for diabetes between October 2004
and October 2005 at the Health Resource Center. Thirty-three surveys were mailed. Only
six participants (18%) completed the survey and agreed to be part of the study by returning
the informed consent and the HIPPA forms. The weight changes and Hgb A1C were
collected only for those subjects.

Data Analysis
The testing instrument included 11 questions (Appendix A). Seven items had answers
limited to true or false; four items were multiple choice questions. The subjects were
instructed to leave the question blank if they did not feel comfortable answering; therefore,
non-response was considered as incorrect. All the survey questions were analyzed using
percentages. The results of these questions are listed in Table 1, with both the number and
percentages of respondents for each question.
Define Type 2 diabetes
The first question addressed subjects’ knowledge of Type 2 diabetes. All participants
had the correct answer on this question (Table 1).
Carbohydrate
The second question was a true or false addressing the carbohydrate metabolism and the
amount of calories it produces. All six respondents answered this question correctly.
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Question number nine defined carbohydrate choices to help participants count their
carbohydrates for each meal. Only four subjects answered correctly (66.6%), (Table 1).
Fiber Intake
The third question addressed the role of a high fiber diet in controlling blood sugar.
Four respondents answered correctly (66.6%), (Table 1).
Obesity
The fourth question indicated the relationship between carbohydrate, protein, and fat
intake and increase in body fat. All six subjects had the correct answer (Table 1).
Symptoms and Complications
Question five identified the most common signs of diabetes: frequent urination and
excessive thirst. All participants were able to recognize these symptoms (Table 1).
The sixth question addressed the relationship between long-term blood sugar management
and diabetes complications. All the respondents answered this question correctly (Table 1).
Question ten dealt specifically with symptoms of low blood sugar. All participants
identified the most common symptoms: feeling shaky and sweaty (Table 1).
Blood Sugar/ Hgb A1C
The seventh question addressed the critical lower limit of blood sugar below which
symptoms of low blood sugar will appear. All participants recognized 70mg/dl is the
critical point. Question eight measured knowledge of expected Hgb A1C results. Only 50%
of participants answered correctly (Table 1). If half of blood sugar results are in the
recommended range the expected Hgb A1C should be about 6%.
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Serving Size
Question 11 tested the knowledge of participants in estimating serving sizes for
carbohydrate counting. Five subjects had the correct answer (83%), (Table 1).

Table 1. Survey question participant responses
Survey
n= 6
No., (%)
Questions

Correct

Incorrect

1) Define Type 2 Diabetes

6 (100%)

0

2) Carbohydrate

6 (100%)

0

3) Fiber Intake

4 (66.6%)

2 (33.3%)

4) Obesity

6 (100%)

0

5) Symptoms

6 (100%)

0

6) Complications

6 (100%)

0

7)Blood Sugar

6 (100%)

0

8) Hgb A1C

3 (50%)

3 (50%)

9) Carbohydrate Choices

4 (66.6%)

2 (33.3%)

Sugar

6 (100%)

0

11) Serving Sizes

5 (83%)

1 (16.6%)

10) Symptoms of Blood
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Weight Changes and Hemoglobin A1C
After analyzing the survey questions, HgbA1C and weight changes of participants were
collected. Percent weight change was calculated for each subject (Table 2). Subjects one
and six lost weight compared to subjects two, three, four, and five who gained weight after
starting the classes (Table 2). In fact, subject two gained 21 pounds or an 8.8% weight gain
within a year of completion of education classes. Subject five gained 25 pounds or a 10%
weight gain within 15 months.

Table 2. Survey and weight change results
Survey score
Subject

% Wt Change

Wt change in pounds

(11 questions)

1

7%

-13

10 (91%)

2

8.80%

21

9 (82%)

3

2.90%

8

10 (91%)

4

1.80%

4

9 (82%)

5

10%

25

10 (91%)

6

0.60%

-1

11 (100%)

The survey scores in Table 2 showed that subjects had good knowledge in diabetes
management. But the weight gain of subject two and five indicates that the application of
their knowledge was minimal even though they answered correctly most of the questions in
the survey. Subject six had a 100% score on his survey, yet lost only one pound and had an
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increase in HgbA1C. There was no significant correlation between weight change and
subject survey score.
Hgb A1C and weight change were also analyzed in graphs to show the relationship
between both variables for each subject. Table 3 shows Hgb A1C and weight changes for
each subject.
Table 3. Weight and Hgb A1C changes for subjects

Subject

Weight

Hgb

Hgb

Hgb

Hgb

Hgb

Hgb

Hgb

change

A1C

A1C

A1C

A1C

A1C

A1C

A1C

change

initial

second third

fourth

fifth

sixth

Number (pound)
1

-13

-2.2

7.8

5.3

5.6

2

21

-3.4

11.2

9.9

6.7

7.8

3

7

0.1

5.9

6.1

6

5.7

6.1

6

4

4

0.1

7.9

7.2

7.2

7.4

8.7

8

5

25

0.4

5.5

5.3

5.5

5.9

6

-1

0.4

6.3

6.2

5.9

6.7

Appendix B shows HgbA1C changes of subject one from June 2005 until July 2006.
HgbA1C decreased from 7.8 to 5.6. At the same time Figure 1 (Appendix B) shows weight
changes from 180 pounds in June 2005 to 167 pounds in October 2006 for this subject.
Subject two showed a HgbA1C decrease from 11.2 in August 2005 to 6.7 in January
2006 accompanied by 1.5 pound initial weight loss (Appendix C, Figure 2). After October
subject two gained 22 pounds until February 2007 (Figure 2).
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Figure 3 shows the fluctuating HgbA1C of subject three (Appendix D). The lowest
HgbA1C was 5.7 in March 2006. Once weight started increasing (Figure 3) Hgb A1C
increased to 6.1 in the same month. Subject four shows the highest HgbA1C 8.7 was in
November 2006; at the same time weight reached the maximum level of 226 pounds in
November 2006 (Appendix E).
The relationship between HgbA1C and weight changes was very obvious for subjects
five and six. Actually, Figure 5 shows increase in Hgb A1C to 5.9 along with an increase of
weight from 245 pounds to 270 pounds. Figure 6 shows fluctuation in HgbA1C from 6.3
in March 2005 to 5.9 in January 2006, then 6.7 in September 2006. HgbA1C changes were
accompanied by weight changes from 150lbs in April 2005 to 144 pounds in August 2005
and back to 150 pounds in July 2006 (Figure 6).
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CHAPTER 5
DISCUSSION, CONCLUSIONS, AND RECOMMENDATIONS

Discussion
Overall, the survey responses indicated a good knowledge of diabetes management
among subjects participating in education classes for diabetes. Although only six subjects
completed the surveys, they answered most of the questions correctly with an average
percentage correct of 89%. Only half of the subjects’ responses were correct regarding
HgbA1C knowledge. One participant expressed his confusion regarding HgbA1C ranges
by giving two answers for this question. Another subject was unable to specify the grams
of carbohydrate in one carbohydrate choice; at the same time he considered high fiber diet
to increase his blood glucose. A possible explanation would be the time lapse in
completing the education classes that made it difficult to remember a lot of details.
Also, the data collected regarding HgbA1C and weight changes indicated a positive
relationship between the variables. Data indicated as weight decreased, HgbA1C
decreased. Some of the participants lost weight, and others gained weight; for some this
resulted in HgbA1C increase.
Unfortunately, the small number of participants in the study did not allow further
statistical analysis to show the exact correlation between variables. Some of the
participants in the study experienced severe health problems and as a result they stopped
exercising that may have led to gaining weight. Others were on oral diabetic medication
and they started on insulin that could have resulted in lower HgbA1C readings.
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Other possible explanations for the differences in how subjects responded to the
program and to changing their eating habits include: 1) availability and type of food that
subjects can afford; 2) lack of compliance to recommendations; 3) one-time education
classes could not ensure the knowledge, the participant’s stage of change, or motivation to
comply (21, 34).

Conclusions
Coordinating this study with the Health Resource Center provided a way to reach all
participants who attended diabetes education classes from October 2004 to October 2005.
The subjects participating in this study were successful in demonstrating good knowledge
of diabetes even though the study participation rate was very low in comparison to 33
mailed surveys. The absence of direct contact with subjects made the participation rate
lower then expected even though all 33 subjects are still enrolled in “Caring For Your
Diabetes” program with the Health Resource Center.
Also, the data showed a positive relationship between HgbA1C and weight changes of
all six subjects. But the direct impact of these subjects’ knowledge on their lifestyle
changes was not conclusive because some of them had actually gained weight. This weight
change could be a result of noncompliance in diet and in carbohydrate counting because
more than a year had passed since completing the education classes.

Recommendations
Reinforcement of the information presented in education classes one year earlier is
essential to promote sustained behavioral change among participants. Follow-up phone
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calls, support groups, and email correspondence could help refresh subjects’ knowledge
and provide motivation. Offering programs like “Caring For Your Diabetes” can be very
beneficial to help participants control their lifestyle changes and blood sugar to prevent any
long-term complications. In addition, long-term studies should be encouraged to analyze
the long-term effect of the education classes. Programs that offer free medications and
decreased insurance rate by offering education classes can motivate participants to better
manage their diabetes. Also, education classes for diabetes can be implemented in a variety
of settings in the community to increase awareness of diabetes and with some degree of
coordination it can be delivered to varying age or management groups to reinforce the
benefits of a healthy lifestyle.
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APPENDICES
APPENDIX A
TESTING INSTRUMENT

Diabetes Knowledge Assessment

Directions: Read each question and decide which choice best completes the statement or answers
the question. Indicate your answer by circling the appropriate letter.
1. With type 2 diabetes, the pancreas secretes too little insulin or insulin that does not work right.
True

False

2. Carbohydrate has 4 calories per gram and turns into blood sugar.
True

False

3. A high fiber diet may increase your blood sugar.
True

False

4. Excess calories from carbohydrate, protein, or fat can increase body fat.
True

False

5. Frequent urination and excessive thirst are signs of diabetes.
True

False

6. Long-term blood sugar management has little impact on diabetes complications.
True

False

7. Low blood sugar is defined greater than 70 mg/dl.
True

False
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8. If at least half (50%) of your blood sugar (glucose) levels are in the recommended target
range your A1C test should be:
a. About 6%
b. About 7%
c. About 8%
9. One carbohydrate choice contains:
a. 5 grams of carbohydrates.
b. 15 grams of carbohydrates.
c. 25 grams of carbohydrates.
10. Symptoms of low blood sugar include:
a. Feeling shaky or sweaty
b. Dry skin.
c. Feeling energetic.
11. A tennis ball is equal in size to _____ serving of fresh fruit (apple, orange, peach, etc):
a. one
b. one-half
c. 1 oz
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APPENDIX B
HgbA1C AND WEIGHT CHANGES OF SUBJECT 1

Figure 1. Hgb A1C and weight changes of subject1
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APPENDIX C
HgbA1C AND WEIGHT CHANGES OF SUBJECT 2

Figure 2. HgbA1C and weight changes of subject 2
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APPENDIX D
HgbA1C AND WEIGHT CHANGES OF SUBJECT 3

Figure 3. HgbA1C and weight changes of subject 3
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APPENDIX E
HgbA1C AND WEIGHT CHANGES OF SUBJECT 4

Figure 4. Hgb A1C and weight changes of subject 4
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APPENDIX F
HgbA1C AND WEIGHT CHANGES OF SUBJECT 5

Figure 5. Hgb A1C and weight changes of subject 5
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APPENDIX G
HgbA1C AND WEIGHT CHANGES OF SUBJECT 6

Figure 6. HgbA1C and weight changes of subject 6
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